Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Growth Regulation|December 1, 1994
Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3P J Fielder, R G Rosenfeld, H C Graves, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|March 1, 1993
Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor IP J Fielder, S E Gargosky, M Vaccarello, et al.
Blood|April 15, 1997
Human platelets as a model for the binding and degradation of thrombopoietinP J Fielder, P Hass, M Nagel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndromeM A Vaccarello, F B Diamond, J Guevara-Aguirre, et al.
Psychoneuroendocrinology|August 1, 1992
Insulin-like growth factors (IGFs): implications for agingP Cohen, I Ocrant, P J Fielder, et al.
Endocrinology|January 6, 2001
Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearanceY Dubaquié, D L Mortensen, A Intintoli, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteinsS E Gargosky, K F Wilson, P J Fielder, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient childrenS F Kemp, P J Fielder, K M Attie, et al.
Pageof 6